Less than half of Americans trust FDA, CDC to do their job
- On May 6, 2025, FDA Commissioner Dr. Marty Makary announced the agency is adopting a more cautious stance on COVID-19 booster approvals in Washington, D.C.
- This cautious approach follows low booster uptake, notably 85% of healthcare workers skipping the last booster, prompting calls for rigorous clinical trials.
- The FDA now requests full clinical trials from vaccine makers and considers limiting booster recommendations mainly to high-risk populations.
- Makary emphasized the importance of relying on rigorous, up-to-date clinical trials rather than drawing conclusions from studies conducted several years ago, highlighting the need for high-quality scientific evidence.
- This new policy may delay booster availability for the next respiratory season and reflects ongoing challenges in public trust and vaccine acceptance.
25 Articles
25 Articles
Less than half of Americans trust FDA, CDC to do their job
Less than half of Americans believe federal health agencies such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) can do key parts of their job, including ensuring new vaccines are safe, poll findings show.

COVID Boosters Might Not Be Updated For Next Season, FDA Commissioner Says
Key Takeaways
Highly educated voters far more satisfied with government COVID response: survey
Two-thirds of Democrats do not believe government overreacted to pandemic, the opposite of Republicans. Majority believes "the worst is behind us," but that's down from two years ago.
Fewer than half of Americans trust FDA, CDC to do their job
(The Hill) - Fewer than half of Americans believe federal health agencies like the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) can do key parts of their job, like ensuring new vaccines are safe, new poll findings show. Five years after the onset of the COVID-19 pandemic, 42 percent of people in the U.S. think federal health agencies are effectively able to respond to infectious disease outbreaks,…
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage